Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: A meta-analysis

Cancer

Volumn 117, Issue 18, 2011, Pages 4312-4324

  Zhang, Yonggang ^a   Zhang, Jie ^b   Deng, Yao ^a   Tian, Can ^a   Li, Xiaobo ^c   Huang, Jin ^a   Fan, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Department of Respiratory Medicine   (China)

Author keywords

cancer; cytotoxic T lymphocyte antigen 4; meta analysis; polymorphism; risk

Indexed keywords

ADENINE; CYTOSINE; GUANINE; THYMINE;

ARTICLE; BREAST CANCER; CANCER RISK; CARDIA CARCINOMA; COLON CANCER; COLORECTAL CANCER; CTLA 4 GENE; ESOPHAGUS CANCER; EUROPE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MELANOMA; MOUTH CANCER; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SKIN CANCER; STOMACH CANCER; THYMOMA; UTERINE CERVIX CANCER;

ANTIGENS, CD; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 80052469506     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25979     Document Type: Article

References (44)

1. Ziogas D, Roukos DH,. Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol. 2009; 16: 1771-1782.
2. Andrew AS, Nelson HH, Kelsey KT, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 2006; 27: 1030-1037.
3. Bredberg A,. Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer. 2011; 117: 440-445.
4. de Visser KE, Eichten A, Coussens LM,. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006; 6: 24-37. (Pubitemid 43053650)
5. Flynn S, Stockinger B,. Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation. Blood. 2003; 101: 4472-4478. (Pubitemid 36857816)
6. Wong YK, Chang KW, Cheng CY, Liu CJ,. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med. 2006; 35: 51-54.
7. Rausch SM, Clark MM, Patten C, et al. Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer. 2010; 116: 4103-4113.
8. Burnet FM,. The concept of immunological surveillance. Prog Exp Tumor Res. 1970; 13: 1-27.
9. Qi P, Ruan CP, Wang H, et al. CTLA-4 +49A→G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int J Colorectal Dis. 2010; 25: 39-45.
10. Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res. 2008; 68: 7025-7034.
11. Su TH, Chang TY, Lee YJ, et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis. 2007; 28: 1237-1240.
12. Sun T, Hu Z, Shen H, Lin D,. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res. 2009; 69: 6011-6014.
13. Scheipers P, Reiser H,. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 cross-linking. Proc Natl Acad Sci U S A. 1998; 95: 10083-10088.
14. Ghaderi A, Yeganeh F, Kalantari T, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat. 2004; 86: 1-7. (Pubitemid 38918893)
15. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J,. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2001; 2: 145-152. (Pubitemid 33674879)
16. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423: 506-511. (Pubitemid 36648570)
17. Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR, Nelson HH,. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res. 2009; 69: 6158-6163.
18. Chuang WY, Strobel P, Gold R, et al. A CTLA-4high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol. 2005; 58: 644-648. (Pubitemid 41377232)
19. Wang L, Li D, Fu Z, Li H, Jiang W, Li D,. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population [serial online]. BMC Cancer. 2007; 7: 173.
20. Piras G, Monne M, Uras A, et al. Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma. Br J Haematol. 2005; 129: 784-790. (Pubitemid 40904529)
21. Khaghanzadeh N, Erfani N, Ghayumi MA, Ghaderi A,. CTLA4 gene variations and haplotypes in patients with lung cancer. Cancer Genet Cytogenet. 2010; 196: 171-174.
22. Bouwhuis MG, Gast A, Figl A, et al. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis? Cancer Immunol Immunother. 2010; 59: 303-312.
23. Solerio E, Tappero G, Iannace L, et al. CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer. Dig Liver Dis. 2005; 37: 170-175. (Pubitemid 41070535)
24. Ivansson EL, Juko-Pecirep I, Gyllensten UB,. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol. 2010; 116: 544-548.
25. Rahimifar S, Erfani N, Sarraf Z, Ghaderi A,. CTLA-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol. 2010; 119: 136-139.
26. Cozar JM, Romero JM, Aptsiauri N, et al. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol. 2007; 68: 698-704. (Pubitemid 47126657)
27. Gu X, Qi P, Zhou F, et al. +49G→A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population. Hum Immunol. 2010; 71: 83-87.
28. Hu L, Liu J, Chen X, et al. CTLA-4 gene polymorphism +49A/G contributes to genetic susceptibility to 2 infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol. 2010; 71: 888-891.
29. Pawlak E, Karabon L, Wlodarska-Polinska I, et al. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Hum Immunol. 2010; 71: 195-200.
30. Suwalska K, Pawlak E, Karabon L, et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population. Hum Immunol. 2008; 69: 193-201.
31. Castro FA, Haimila K, Sareneva I, et al. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-a candidate gene approach. Int J Cancer. 2009; 125: 1851-1858.
32. Dilmec F, Ozgonul A, Uzunkoy A, Akkafa F,. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet. 2008; 35: 317-321.
33. Xiao M, Qi F, Chen X, et al. Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. Int J Immunogenet. 2010; 37: 27-32.
34. Cheng TY, Lin JT, Chen LT, et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2006; 24: 3483-3489.
35. Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A,. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol. 2007; 22: 2283-2287. (Pubitemid 350145629)
36. Mahajan R, El-Omar EM, Lissowska J, et al. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol. 2008; 38: 626-633.
37. Kammerer PW, Toyoshima T, Schoder F, et al. Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma. Oral Oncol. 2010; 46: 543-548.
38. Li H, Fu ZK, Wang LH, et al. [Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms with susceptibility to breast cancer]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008; 24: 282-284.
39. Zhang Y, Zhang J, Huang J, et al. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: a meta-analysis. Respirology. 2010; 15: 643-650.
40. Li F, Sturgis EM, Chen X, Zafereo ME, Wei Q, Li G,. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer. 2010; 116: 2350-2359.
41. Wang G, Yu D, Tan W, Zhao D, Wu C, Lin D,. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma. Cancer. 2009; 115: 2430-2437.
42. Kristensen VN, Borresen-Dale AL,. SNPs associated with molecular subtypes of breast cancer: on the usefulness of stratified Genome-Wide Association Studies (GWAS) in the identification of novel susceptibility loci. Mol Oncol. 2008; 2: 12-15. (Pubitemid 351685817)
43. Kraft P, Haiman CA,. GWAS identifies a common breast cancer risk allele among BRCA1 carriers. Nat Genet. 2010; 42: 819-820.
44. Gorlov IP, Gallick GE, Gorlova OY, Amos C, Logothetis CJ,. GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example [serial online]. PLoS One. 2009; 4: e6511.